A citation-based method for searching scientific literature

Alexander Drilon, Lu Wang, Maria E Arcila, Sohail Balasubramanian, Joel R Greenbowe, Jeffrey S Ross, Phil Stephens, Doron Lipson, Vincent A Miller, Mark G Kris, Marc Ladanyi, Naiyer A Rizvi. Clin Cancer Res 2015
Times Cited: 150



Benjamin J Solomon, Tony Mok, Dong-Wan Kim, Yi-Long Wu, Kazuhiko Nakagawa, Tarek Mekhail, Enriqueta Felip, Federico Cappuzzo, Jolanda Paolini, Tiziana Usari, Shrividya Iyer, Arlene Reisman, Keith D Wilner, Jennifer Tursi, Fiona Blackhall. N Engl J Med 2014
Times Cited: 1774




List of shared articles



Times cited

2020 Innovation-Based Optimism for Lung Cancer Outcomes.
Erin L Schenk, Tejas Patil, Jose Pacheco, Paul A Bunn. Oncologist 2021
0

Identification of novel ALK fusions using DNA/RNA sequencing in immunohistochemistry / RT-PCR discordant NSCLC patients.
Bei Wang, Rongrong Chen, Changxi Wang, Jia Guo, Mingming Yuan, Huang Chen, Xuefeng Xia, Dingrong Zhong. Hum Pathol 2021
0

Novel ALK-specific mRNA in situ hybridization assay for non-small-cell lung carcinoma.
Noriko Hirai, Takaaki Sasaki, Shunsuke Okumura, Masatoshi Sado, Naoko Akiyama, Masahiro Kitada, Hidehiro Takei, Yoshinobu Ohsaki. Transl Lung Cancer Res 2020
3

Targeted Gene Next-Generation Sequencing Panel in Patients with Advanced Lung Adenocarcinoma: Paving the Way for Clinical Implementation.
Maria Gabriela O Fernandes, Maria Jacob, Natália Martins, Conceição Souto Moura, Susana Guimarães, Joana Pereira Reis, Ana Justino, Maria João Pina, Luís Cirnes, Catarina Sousa,[...]. Cancers (Basel) 2019
11

Diagnosis and Treatment of ALK Aberrations in Metastatic NSCLC.
Alex Friedlaender, Giuseppe Banna, Sandip Patel, Alfredo Addeo. Curr Treat Options Oncol 2019
13

Targeting RET-driven cancers: lessons from evolving preclinical and clinical landscapes.
Alexander Drilon, Zishuo I Hu, Gillianne G Y Lai, Daniel S W Tan. Nat Rev Clin Oncol 2018
98

ALK fusion variants detection by targeted RNA-next generation sequencing and clinical responses to crizotinib in ALK-positive non-small cell lung cancer.
Anne McLeer-Florin, Michael Duruisseaux, Julian Pinsolle, Sylvian Dubourd, Julie Mondet, Mathilde Phillips Houlbracq, Nelly Magnat, Julien Fauré, Amandine Chatagnon, Florence de Fraipont,[...]. Lung Cancer 2018
33

Characteristics and Outcome of ROS1-Positive Non-Small Cell Lung Cancer Patients in Routine Clinical Practice.
Sehhoon Park, Beung-Chul Ahn, Sung Won Lim, Jong-Mu Sun, Hye Ryun Kim, Min Hee Hong, Se-Hoon Lee, Jin Seok Ahn, Keunchil Park, Yoon La Choi,[...]. J Thorac Oncol 2018
39

Common cancer-driver mutations and their association with abnormally methylated genes in lung adenocarcinoma from never-smokers.
Mathewos Tessema, Michael R Rossi, Maria A Picchi, Christin M Yingling, Yong Lin, Suresh S Ramalingam, Steven A Belinsky. Lung Cancer 2018
2